Total Payments
$63,087
2024 Payments
$1,860
Companies
72
Transactions
714
Payment Breakdown by Category
Other$33,857 (53.7%)
Food & Beverage$13,469 (21.3%)
Consulting$6,887 (10.9%)
Travel$5,748 (9.1%)
Research$3,000 (4.8%)
Education$125.58 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $33,857 | 28 | 53.7% |
| Food and Beverage | $13,469 | 635 | 21.3% |
| Consulting Fee | $6,887 | 6 | 10.9% |
| Travel and Lodging | $5,748 | 28 | 9.1% |
| Unspecified | $3,000 | 2 | 4.8% |
| Education | $125.58 | 15 | 0.2% |
Payments by Type
General
$60,087
712 transactions
Research
$3,000
2 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Sunovion Pharmaceuticals Inc. | $22,558 | 66 | $0 (2022) |
| AQUESTIVE THERAPEUTICS, INC. | $13,296 | 39 | $0 (2024) |
| Greenwich Biosciences, Inc. | $5,007 | 13 | $0 (2021) |
| SK Life Science, Inc. | $4,403 | 32 | $0 (2024) |
| PFIZER INC. | $3,015 | 3 | $0 (2023) |
| UCB, Inc. | $2,128 | 54 | $0 (2024) |
| Zogenix Inc. | $1,482 | 4 | $0 (2021) |
| JAZZ PHARMACEUTICALS INC. | $1,310 | 23 | $0 (2024) |
| LivaNova USA, Inc. | $988.42 | 18 | $0 (2024) |
| Neurelis, Inc. | $872.37 | 35 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,860 | 85 | Neurelis, Inc. ($404.03) |
| 2023 | $9,317 | 103 | SK Life Science, Inc. ($4,064) |
| 2022 | $4,927 | 169 | UCB, Inc. ($1,161) |
| 2021 | $7,593 | 112 | Greenwich Biosciences, Inc. ($4,423) |
| 2020 | $645.53 | 8 | AQUESTIVE THERAPEUTICS, INC. ($600.00) |
| 2019 | $13,331 | 36 | Aquestive Therapeutics, Inc. ($12,489) |
| 2018 | $9,597 | 46 | Sunovion Pharmaceuticals Inc. ($8,689) |
| 2017 | $15,817 | 155 | Sunovion Pharmaceuticals Inc. ($13,434) |
All Payment Transactions
714 individual payment records from CMS Open Payments — Page 1 of 29
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $34.77 | General |
| Category: Neurology | ||||||
| 12/17/2024 | Aucta Pharmaceuticals, Inc. | Motpoly XR (Drug) | Food and Beverage | In-kind items and services | $18.49 | General |
| Category: Central Nervous System | ||||||
| 12/11/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $12.26 | General |
| Category: Neurology | ||||||
| 12/10/2024 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $32.91 | General |
| Category: EPILEPSY | ||||||
| 12/09/2024 | Abbott Laboratories | ETERNA (Device) | Food and Beverage | In-kind items and services | $21.16 | General |
| Category: Neuromodulation | ||||||
| 12/04/2024 | Aucta Pharmaceuticals, Inc. | Motpoly XR (Drug) | Food and Beverage | In-kind items and services | $21.00 | General |
| Category: Central Nervous System | ||||||
| 11/27/2024 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $31.36 | General |
| Category: Neurology | ||||||
| 11/21/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $25.17 | General |
| Category: Neurology | ||||||
| 11/18/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $9.18 | General |
| Category: Neurology | ||||||
| 11/14/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $24.97 | General |
| Category: Rare Disease | ||||||
| 11/12/2024 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $35.66 | General |
| Category: EPILEPSY | ||||||
| 11/12/2024 | Aucta Pharmaceuticals, Inc. | Motpoly XR (Drug) | Food and Beverage | In-kind items and services | $14.38 | General |
| Category: Central Nervous System | ||||||
| 11/11/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $15.13 | General |
| Category: Neurology | ||||||
| 10/24/2024 | UCB, Inc. | Fintepla (Drug) | Food and Beverage | In-kind items and services | $28.66 | General |
| Category: Neurology | ||||||
| 10/23/2024 | Aucta Pharmaceuticals, Inc. | Motpoly XR (Drug) | Food and Beverage | In-kind items and services | $16.43 | General |
| Category: Central Nervous System | ||||||
| 10/17/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $26.50 | General |
| Category: Rare Disease | ||||||
| 10/16/2024 | AQUESTIVE THERAPEUTICS, INC. | LIBERVANT (Drug) | Food and Beverage | In-kind items and services | $20.66 | General |
| Category: Central Nervous System | ||||||
| 10/15/2024 | UCB, Inc. | Fintepla (Drug) | Food and Beverage | In-kind items and services | $32.80 | General |
| Category: Neurology | ||||||
| 10/14/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $12.09 | General |
| Category: Neurology | ||||||
| 10/08/2024 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $30.32 | General |
| Category: EPILEPSY | ||||||
| 09/24/2024 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $33.69 | General |
| Category: EPILEPSY | ||||||
| 09/23/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $16.28 | General |
| Category: Neurology | ||||||
| 09/17/2024 | Aucta Pharmaceuticals, Inc. | Motpoly XR (Drug) | Food and Beverage | In-kind items and services | $21.91 | General |
| Category: Central Nervous System | ||||||
| 09/12/2024 | Azurity Pharmaceuticals, Inc. | HORIZANT (Drug) | Food and Beverage | In-kind items and services | $14.26 | General |
| Category: CEREBROVASCULARCNS | ||||||
| 09/11/2024 | Sumitomo Pharma America, Inc. | APTIOM (Drug) | Food and Beverage | In-kind items and services | $18.88 | General |
| Category: NEUROLOGY | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| PHASE 3 MULTICENTER OPENLABEL STUDY TO ASSESS THE LONGTERM SAFETY AND TOLERABILITY OF RIMEGEPANT FOR THE ACUTE TREATMENT OF MIGRAINE WITH OR WITHOUT AURA IN CHILDREN AND ADOLESCENTS 6 TO 18 YEARS OF AGE | PFIZER INC. | $1,500 | 1 |
| PHASE 3 MULTICENTER RANDOMIZED DOUBLEBLIND GROUP SEQUENTIAL PLACEBOCONTROLLED STUDY TO ASSESS EFFICACY AND SAFETY OF RIMEGEPANT FOR THE TREATMENT OF MIGRAINE WITH OR WITHOUT AURA IN CHILDREN AND ADOLESCENTS 6 TO 18 YEARS OF AGE | PFIZER INC. | $1,500 | 1 |
About Dr. Robert Nahouraii, MD
Dr. Robert Nahouraii, MD is a Pediatrics healthcare provider based in Concord, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1104877224.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Nahouraii, MD has received a total of $63,087 in payments from pharmaceutical and medical device companies, with $1,860 received in 2024. These payments were reported across 714 transactions from 72 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($33,857).
Ad
Practice Information
- Specialty Pediatrics
- Other Specialties Neurology with Special Qualifications in Child Neurology, Neurology with Special Qualifications in Child Neurology
- Location Concord, NC
- Active Since 05/13/2006
- Last Updated 12/06/2023
- Taxonomy Code 208000000X
- Entity Type Individual
- NPI Number 1104877224
Products in Payments
- APTIOM (Drug) $23,093
- SYMPAZAN (Drug) $13,213
- Epidiolex (Drug) $5,007
- XCOPRI (Drug) $3,797
- NURTEC ODT (Drug) $3,523
- Fintepla (Drug) $2,833
- EPIDIOLEX (Drug) $1,026
- VALTOCO (Drug) $872.37
- VNS Therapy (Device) $831.53
- Fycompa (Drug) $744.35
- Briviact (Drug) $584.14
- AUSTEDO (Drug) $406.68
- ULTOMIRIS (Biological) $253.73
- Motpoly XR (Drug) $211.98
- Betaseron (Drug) $183.58
- NUPLAZID (Drug) $171.46
- LEMTRADA (Drug) $168.56
- Xeomin (Biological) $158.05
- TROKENDI XR (Drug) $143.96
- VNS THERAPY SENTIVA MODEL 1000 GENERATOR (Device) $142.09
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pediatrics Doctors in Concord
Matthew Saxonhouse, Md, MD
Pediatrics — Payments: $5,048
Pediatrics $5,048
Trang Vuong, Md, MD
Pediatrics — Payments: $4,718
Pediatrics $4,718
Sarah Medeiros, Arnp, ARNP
Pediatrics — Payments: $4,613
Pediatrics $4,613
Hemant Prakash, Md, MD
Pediatrics — Payments: $3,073
Pediatrics $3,073
Linda Agyapong, M.d, M.D
Pediatrics — Payments: $1,560
Pediatrics $1,560
Julia Blevins Richards, Md, MD
Pediatrics — Payments: $1,312
Pediatrics $1,312